Abstract:5573 Background: Primary treatment of advanced ovarian cancer includes both chemotherapy and tumor reductive surgery (TRS), with the best outcomes seen in those patients in whom complete gross resection can be achieved. Real-time identification of metastatic ovarian cancer lesions in vivo during TRS can be challenging following neoadjuvant chemotherapy (NACT). In this study, we investigated the feasibility of using the hand-held MasSpec Pen (MSP) technology for intraoperative molecular analysis and tissue identification of metastatic sites during ovarian cancer TRS. The MSP is an innovative hand-held probe coupled to a mass spectrometer that non-destructively analyzes the metabolic composition of tissues in <20 seconds. Methods: Patients with advanced high grade serous carcinoma (HGSC) who received NACT and were scheduled for interval TRS were consented prior to their surgery. An Orbitrap Exploris mass spectrometer equipped with a MSP source was placed ~5 m away from the operating table. The MSP device was produced in the Eberlin lab and sterilized on-site prior to surgical use. In vivo MSP measurements were performed by gynecologic oncology surgeons and ex vivomeasurements were made by clinical research personnel. For each surgical case, 6 tissue sites were analyzed intraoperatively at the discretion of the surgeon including the primary tumor, 3 distinct normal peritoneum sites, and two suspicious metastatic sites. Research analysis sites were marked with surgical ink for pathological analysis. Direct correlation of intraoperative molecular analysis was made with final pathologic results. The data was used to build statistical classifiers using the Lasso predictive model. Results: Forty-four patients with advanced HGSC underwent interval TRS with MSP analysis, yielding 93 unique MSP in vivo analyses. Median age was 62.5 years (range 32-85 years). Most patients were diagnosed with stage IV (53%) disease and ovarian cancer primaries (85%). Majority of interval TRS was performed after 3-4 cycles of NACT (71%). From our 93 in vivo MSP analyses, 75 samples were chosen as our training set, and 18 samples chosen for our testing set. The MSP profiles were characterized by high relative abundance of small metabolites and glycerophospholipids, and consistent with prior data from ex vivo tissues. We demonstrated feasibility of utilizing the hand-held MSP in vivo, with preliminary accuracy of 89% in our training set and 88% in our testing set to predict cancer versus non-cancer tissue samples using the Lasso predictive model compared to final pathology. Conclusions: Intraoperative data collection utilizing the hand-held MSP is feasible and can be used in combination with statistical classifiers for real time disease-state diagnosis during TRS to distinguish ovarian cancer from normal tissues.

Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue

Identification of tumor tissue in thin pathological samples via femtosecond laser-induced breakdown spectroscopy and machine learning

Visible and near-infrared spectroscopy for distinguishing malignant tumor tissue from benign tumor and normal breast tissues in vitro

Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy

Intraoperative assessment of resection margins by Raman spectroscopy to guide oral cancer surgery.

Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance

Intraoperative Diagnosis Of Benign And Malignant Breast Tissues By Fourier Transform Infrared Spectroscopy And Support Vector Machine Classification

Optical spectroscopy-based imaging techniques for the diagnosis of breast cancer: A novel approach

Macroscopic inelastic scattering imaging using a hyperspectral line-scanning system identifies invasive breast cancer in lumpectomy and mastectomy specimens

Toward the use of diffuse reflection spectroscopy for intra-operative tissue discrimination during sarcoma surgery

Electrical Impedance Spectroscopy for Ex-Vivo Breast Cancer Tissues Analysis

Real-time oncological guidance using diffuse reflectance spectroscopy in electrosurgery: the effect of coagulation on tissue discrimination

Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.

Pterygium and Ocular Surface Squamous Neoplasia: Optical Biopsy Using a Novel Autofluorescence Multispectral Imaging Technique

A Noninvasive Multimodal Sono-Contrast NIR Spectroscopy System for Breast Cancer Diagnosis: Clinical Trial.

Single probe light reflectance spectroscopy and parameter spectrum feature extraction in experimental skin cancer detection and classification

In vivo assessment of bladder cancer with diffuse reflectance and fluorescence spectroscopy: A comparative study

Real-time classification of tumour and non-tumour tissue in colorectal cancer using diffuse reflectance spectroscopy and neural networks to aid margin assessment

Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry

Multimodal Optical Coherence Tomography for Intraoperative Evaluation of Tumor Margins and Surgical Margins in Breast-Conserving Surgery

Automated assessment of breast margins in deep ultraviolet fluorescence images using texture analysis